Curative Biotechnology (CUBT) Stock Price, News & Analysis

Company Overview

Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

Key Stats

• Today's Range: $0.0080 to $0.0093
• 50-Day Range: $0.0079 to $0.0149
• 52-Week Range: $0.00 to $0.03
• Volume: 12,000 shs
• Average Volume: 164,666 shs
• Market Capitalization: $9.42 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CUBT Stock Analysis - Frequently Asked Questions

How have CUBT shares performed this year?

Curative Biotechnology's stock was trading at $0.0128 at the beginning of 2025. Since then, CUBT shares have decreased by 27.3% and is now trading at $0.0093.

How do I buy shares of Curative Biotechnology?

Shares of CUBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Curative Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Ayala Pharmaceuticals (ADXS), Curative Biotechnology (CTYX), Invesco S&P Global Water Index ETF (CGW), Surge Battery Metals (NILIF), HEXO (HEXO), Pressure BioSciences (PBIO) and ACRO (TACI).

Company Calendar

• Today: 8/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CUBT
• CIK: 1400271
• Web: curativebiotech.com
• Phone: (561) 418-7725
• Fax: 866-900-1002
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,012,760,000
• Free Float: N/A
• Market Cap: $9.42 million
• Optionable: Not Optionable
• Beta: 0.20